Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Janae Davis"'
Autor:
Jonathan Goldberg, Ricardo G. Pastorello, Tuulia Vallius, Janae Davis, Yvonne Xiaoyong Cui, Judith Agudo, Adrienne G. Waks, Tanya Keenan, Sandra S. McAllister, Sara M. Tolaney, Elizabeth A. Mittendorf, Jennifer L. Guerriero
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Immune checkpoint blockade (ICB) has revolutionized the treatment of cancer patients. The main focus of ICB has been on reinvigorating the adaptive immune response, namely, activating cytotoxic T cells. ICB has demonstrated only modest benefit agains
Externí odkaz:
https://doaj.org/article/c6f1d16fe8fe4156b1a30d4cfc2352a3
Autor:
Sara M. Tolaney, Geoffrey I. Shapiro, Eliezer M. Van Allen, Elizabeth A. Mittendorf, Eric P. Winer, Beth Overmoyer, Alan D'Andrea, Peter K. Sorger, Robert E. Godin, Erin Shannon, Meng X. He, Jake Conway, Leilani Anderson, Rie K. Tahara, Ricardo Pastorello, Janae Davis, Bose Kochupurakkal, Nabihah Tayob, Jennifer L. Guerriero, Tuulia Vallius, Tianyu Li, Tanya E. Keenan
Supplementary Table 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d6e7627cc9ddf60f5a02e2b2dc2aff9
https://doi.org/10.1158/1078-0432.22478834
https://doi.org/10.1158/1078-0432.22478834
Autor:
Sara M. Tolaney, Geoffrey I. Shapiro, Eliezer M. Van Allen, Elizabeth A. Mittendorf, Eric P. Winer, Beth Overmoyer, Alan D'Andrea, Peter K. Sorger, Robert E. Godin, Erin Shannon, Meng X. He, Jake Conway, Leilani Anderson, Rie K. Tahara, Ricardo Pastorello, Janae Davis, Bose Kochupurakkal, Nabihah Tayob, Jennifer L. Guerriero, Tuulia Vallius, Tianyu Li, Tanya E. Keenan
Supplemental methods, results, figures, tables, and references
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22081d2f5cb611bcfbd5caf0bef6ff19
https://doi.org/10.1158/1078-0432.22478837.v1
https://doi.org/10.1158/1078-0432.22478837.v1
Autor:
Sara M. Tolaney, Geoffrey I. Shapiro, Eliezer M. Van Allen, Elizabeth A. Mittendorf, Eric P. Winer, Beth Overmoyer, Alan D'Andrea, Peter K. Sorger, Robert E. Godin, Erin Shannon, Meng X. He, Jake Conway, Leilani Anderson, Rie K. Tahara, Ricardo Pastorello, Janae Davis, Bose Kochupurakkal, Nabihah Tayob, Jennifer L. Guerriero, Tuulia Vallius, Tianyu Li, Tanya E. Keenan
Purpose:We report results from a phase II study assessing the efficacy of the WEE1 inhibitor adavosertib with cisplatin in metastatic triple-negative breast cancer (mTNBC).Patients and Methods:Patients with mTNBC treated with 0–1 prior lines of che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ed6d60c813390640a1c4f4d62c02d56
https://doi.org/10.1158/1078-0432.c.6530060
https://doi.org/10.1158/1078-0432.c.6530060
Autor:
Jennifer L Guerriero, Gregory J Baker, Jia-Ren Lin, Yu-An Chen, Ricardo Pastorello, Tuulia Vallius, Janae Davis, Clarence Yapp, Sarah E Church, Eric Miller, Anniina Färkkilä, Shaveta Vinayak, Melinda L Telli, Giulia Fulci, Alan D'Andrea, Geoffrey I Shapiro, Sara M Tolaney, Sandro Santagata, Peter K Sorger, Elizabeth A Mittendorf
Publikováno v:
Cancer Research. 82:P2-07
Background: TOPACIO was a phase I/II study evaluating the PARP inhibitor (PARPi) niraparib in combination with the anti-PD-1 antibody pembrolizumab in patients with locally advanced and metastatic triple-negative breast cancer (TNBC, n=55) and ovaria
Autor:
Janae Davis
Publikováno v:
Environment and Planning E: Nature and Space. 2:89-109
The Wilderness Act of 1964 defines wilderness as “an area where the earth and its community of life are untrammeled by man, where man himself is a visitor who does not remain”. It goes on to limit acceptable activities in designated wilderness ar
Autor:
Kenichi Shimada, Yvonne X Cui, Jonathan S Goldberg, Ricardo Pastorello, Janae Davis, Tuulia Vallius, Lukas Kania, Ashka Patel, Mckenna Moore, Esther R Ogayo, Deborah Dillon, Peter K Sorger, Jennifer L Guerriero, Elizabeth A Mittendorf
Publikováno v:
Cancer Research. 82:P4-04
Background Clinical trials have shown minimal activity of immune checkpoint blockade (ICB) in HR+ breast cancer. While this is, in part, attributable to low tumor-infiltrating lymphocyte (TIL) levels in HR+ breast cancer, a thorough investigation of
Autor:
Jennifer L. Guerriero, Tuulia Vallius, Eliezer M. Van Allen, Sara M. Tolaney, Ricardo G. Pastorello, Tianyu Li, Rie K. Tahara, Alan D. D'Andrea, Erin Shannon, Eric P. Winer, Nabihah Tayob, Bose Kochupurakkal, Tanya Keenan, Elizabeth A. Mittendorf, Geoffrey I. Shapiro, Leilani Anderson, Meng Xiao He, Robert Godin, Beth Overmoyer, Peter K. Sorger, Jake Conway, Janae Davis
Publikováno v:
Clin Cancer Res
Purpose: We report results from a phase II study assessing the efficacy of the WEE1 inhibitor adavosertib with cisplatin in metastatic triple-negative breast cancer (mTNBC). Patients and Methods: Patients with mTNBC treated with 0–1 prior lines of
Publikováno v:
The SAGE Handbook of Historical Geography
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58c12d8a86b7dec706c2c0c65673500d
https://doi.org/10.4135/9781529739954.n11
https://doi.org/10.4135/9781529739954.n11
Publikováno v:
Geography Compass. 13:e12438